Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the US Department … DK Smith, LA Grohskopf, RJ Black, JD Auerbach, F Veronese, KA Struble, ...
MMWR Recomm Rep 54 (RR-2), 1-20, 2005
782 2005 Chemical and physical methods RL Bradley, E Arnold, DM Barbano, RG Semerad, DE Smith, BK Vines
Standard methods for the examination of dairy products 16, 433-531, 1992
594 1992 Measurement and characterization of postischemic free radical generation in the isolated perfused heart JL Zweier, P Kuppusamy, R Williams, BK Rayburn, D Smith, ML Weisfeldt, ...
Journal of Biological Chemistry 264 (32), 18890-18895, 1989
478 1989 Threshold velocities for input of soil particles into the air by desert soils DA Gillette, J Adams, A Endo, D Smith, R Kihl
Journal of Geophysical Research: Oceans 85 (C10), 5621-5630, 1980
456 1980 Treatment of advanced breast cancer with sterically stabilized liposomal doxorubicin: results of a multicenter phase II trial. MR Ranson, J Carmichael, K O'byrne, S Stewart, D Smith, A Howell
Journal of Clinical Oncology 15 (10), 3185-3191, 1997
361 1997 Freeze-out conditions in heavy ion collisions from QCD thermodynamics A Bazavov, HT Ding, P Hegde, O Kaczmarek, F Karsch, E Laermann, ...
Physical review letters 109 (19), 192302, 2012
333 2012 Effect of fluorouracil, leucovorin, and oxaliplatin with or without onartuzumab in HER2-negative, MET-positive gastroesophageal adenocarcinoma: the METGastric randomized … MA Shah, YJ Bang, F Lordick, M Alsina, M Chen, SP Hack, JM Bruey, ...
JAMA oncology 3 (5), 620-627, 2017
325 2017 Results from the phase III randomized trial of onartuzumab plus erlotinib versus erlotinib in previously treated stage IIIB or IV non–small-cell lung cancer: METLung DR Spigel, MJ Edelman, K O’Byrne, L Paz-Ares, S Mocci, S Phan, ...
Journal of Clinical Oncology 35 (4), 412-420, 2017
294 2017 Differential regulation of PD-L1 expression by immune and tumor cells in NSCLC and the response to treatment with atezolizumab (anti–PD-L1) M Kowanetz, W Zou, SN Gettinger, H Koeppen, M Kockx, P Schmid, ...
Proceedings of the National Academy of Sciences 115 (43), E10119-E10126, 2018
235 2018 RORγt inhibition selectively targets IL-17 producing iNKT and γδ-T cells enriched in Spondyloarthritis patients K Venken, P Jacques, C Mortier, ME Labadia, T Decruy, J Coudenys, ...
Nature communications 10 (1), 9, 2019
184 2019 Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer S Rao, D Cunningham, RE Hawkins, ME Hill, D Smith, F Daniel, PJ Ross, ...
British journal of cancer 92 (9), 1650-1654, 2005
178 2005 Development of a PD-L1 complementary diagnostic immunohistochemistry assay (SP142) for atezolizumab B Vennapusa, B Baker, M Kowanetz, J Boone, I Menzl, JM Bruey, G Fine, ...
Applied Immunohistochemistry & Molecular Morphology 27 (2), 92-100, 2019
177 2019 Common Consensus: a web-based game for collecting commonsense goals H Lieberman, D Smith, A Teeters
ACM Workshop on Common Sense for Intelligent Interfaces, 2007
164 2007 Epidemiological characteristics, practice of ventilation, and clinical outcome in patients at risk of acute respiratory distress syndrome in intensive care units from 16 … AS Neto, CSV Barbas, FD Simonis, A Artigas-Raventós, J Canet, ...
The Lancet Respiratory Medicine 4 (11), 882-893, 2016
163 2016 Raman spectroscopic studies of gasochromic a-WO3 thin films SH Lee, HM Cheong, P Liu, D Smith, CE Tracy, A Mascarenhas, JR Pitts, ...
Electrochimica Acta 46 (13-14), 1995-1999, 2001
145 2001 Asphalt pavement cracking: analysis of extraordinary life cycle variability in eastern and northeastern Ontario SAM Hesp, A Soleimani, S Subramani, T Phillips, D Smith, P Marks, ...
International Journal of Pavement Engineering 10 (3), 209-227, 2009
141 2009 Gasochromic mechanism in SH Lee, HM Cheong, P Liu, D Smith, CE Tracy, A Mascanrenhas, JR Pitts, ...
Journal of Applied Physics 88 (5), 3076-3078, 2000
131 2000 It's all good: Corporate social responsibility reduces negative and promotes positive responses to service failures among value-aligned customers J Joireman, D Smith, RL Liu, J Arthurs
Journal of Public Policy & Marketing 34 (1), 32-49, 2015
128 2015 Treating depression: the beyondblue guidelines for treating depression in primary care." Not so much what you do but that you keep doing it". PM Ellis, DA Smith
The Medical Journal of Australia 176, S77-83, 2002
127 2002 Mechanisms of acinar cell injury in acute pancreatitis MGT Raraty, JA Murphy, E Mcloughlin, D Smith, D Criddle, R Sutton
Scandinavian journal of surgery 94 (2), 89-96, 2005
116 2005 
Henry LiebermanPrincipal Research Scientist, Massachsuetts Institute of TechnologyAdresă de e-mail confirmată pe media.mit.edu